Titan Pharmaceuticals Inc (TTNP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Titan Pharmaceuticals Inc (TTNP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7477
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probuphine for the treatment of opioid addiction, repinirole implant for treating Parkinson’s disease and T3 implant for the treatment of hypothyroidism. Titan also develops product candidates for the treatment of hormonal deficiencies including type 2diabetes, attention deficit hyperactivity disorder, benign prostate hyperplasia, and others. The company also partners with other companies for delivery of other compounds using ProNeura technology. Titan is headquartered in South San Francisco, California, the US.

Titan Pharmaceuticals Inc (TTNP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Titan Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Titan Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Titan Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Titan Pharma to Raise USD9.5 Million in Public Offering of Units 10
Titan Pharma Raises USD1.3 Million in Private Placement of Shares upon Exercise of Series A Warrants 12
Titan Pharma Raises USD4 Million in Private Placement of Shares upon Exercise of Series B Warrants 13
Titan Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Series B Warrants 14
Titan Pharmaceuticals Inc – Key Competitors 15
Titan Pharmaceuticals Inc – Key Employees 16
Titan Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Aug 14, 2018: Titan Pharmaceuticals announces Second Quarter 2018 Financial Results 18
May 15, 2018: Titan Pharmaceuticals Announces First Quarter 2018 Financial Results 19
Apr 02, 2018: Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results 20
Nov 09, 2017: Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results 22
Aug 09, 2017: Titan Pharmaceuticals Reports Second Quarter 2017 Financial Results 24
Jul 27, 2017: Titan Pharmaceuticals Secures $10 Million Debt Facility From Horizon Technology Finance 26
May 10, 2017: Titan Pharmaceuticals Reports First Quarter 2017 Financial Results 27
Mar 16, 2017: Titan Pharmaceuticals Reports Full Year And Fourth Quarter 2016 Financial Results 29
Corporate Communications 31
Jul 27, 2017: Titan Pharmaceuticals Secures $10 Million Debt Facility From Horizon Technology Finance 31
Jan 04, 2017: Titan Pharmaceuticals Appoints Two New Board Members 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Titan Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Titan Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Titan Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Titan Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Titan Pharma to Raise USD9.5 Million in Public Offering of Units 10
Titan Pharma Raises USD1.3 Million in Private Placement of Shares upon Exercise of Series A Warrants 12
Titan Pharma Raises USD4 Million in Private Placement of Shares upon Exercise of Series B Warrants 13
Titan Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Series B Warrants 14
Titan Pharmaceuticals Inc, Key Competitors 15
Titan Pharmaceuticals Inc, Key Employees 16

List of Figures
Titan Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Titan Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Titan Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Titan Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Titan Pharmaceuticals Inc (TTNP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Invictus Oncology Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Invictus Oncology Pvt Ltd (Invictus Oncology) is a biopharmaceutical company with focus on the discovery, development and commercialization of anti-cancer drugs. The company develops platinum-based drugs to treat various types of cancers. It engineers platinum-based drugs harnessing structur …
  • Electricity Generating Authority of Thailand:企業の戦略的SWOT分析
    Electricity Generating Authority of Thailand - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Air Lease Corporation:企業の戦略・SWOT・財務情報
    Air Lease Corporation - Strategy, SWOT and Corporate Finance Report Summary Air Lease Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consu …
  • The Cato Corporation:企業の戦略・SWOT・財務情報
    The Cato Corporation - Strategy, SWOT and Corporate Finance Report Summary The Cato Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Bank of Nagoya, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Nagoya, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Nagoya, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Delta Electronics (Thailand) Public Company Ltd. (DELTA):企業の財務・戦略的SWOT分析
    Delta Electronics (Thailand) Public Company Ltd. (DELTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • OncoMed Pharmaceuticals Inc (OMED):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • Trammo Inc.:企業の戦略・SWOT・財務情報
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Big Rivers Electric Corporation:発電所・企業SWOT分析
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Libbs Farmaceutica Ltda:製薬・医療:M&Aディール及び事業提携情報
    Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which manufactures and supply medications for human healthcare. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central n …
  • Engineers India Ltd (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Ltd (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • Itamar Medical Ltd (ITMR)-医療機器分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Orange Belgium (OBEL):企業の戦略的SWOT分析
    Orange Belgium (OBEL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆